Compare MIND & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIND | LUNG |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 72.2M |
| IPO Year | N/A | 2020 |
| Metric | MIND | LUNG |
|---|---|---|
| Price | $8.10 | $1.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 102.0K | ★ 645.4K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $83,789,000.00 |
| Revenue This Year | N/A | $6.20 |
| Revenue Next Year | $8.08 | $21.61 |
| P/E Ratio | $22.27 | ★ N/A |
| Revenue Growth | N/A | ★ 22.01 |
| 52 Week Low | $4.45 | $1.31 |
| 52 Week High | $14.50 | $8.10 |
| Indicator | MIND | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 55.32 |
| Support Level | $7.91 | $1.44 |
| Resistance Level | $9.27 | $1.93 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 55.15 | 48.67 |
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.